Viritis
Next-generation antisense-based antiviral treatments
Active
Pre-Seed
Startup
Petah Tikva
Founded 2023-01
Viritis is a biotech company pioneering a next-generation antisense-based platform for rapid development of antiviral drugs. Our novel technology targets all strains of a given virus, offering a scalable and precise solution for current and emerging viral threats. Our platform combines AI-driven algorithms with patented molecule design to bind specifically…
SectorHealth Tech & Life Sciences
StagePre-Seed
Total raised$665K
Employees4
Founded2023-01
HQPetah Tikva
Patents1
Confidence98
Sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technology
Artificial IntelligenceMaterials & SubstancesNanomaterialsBiologicalsCellsMolecules
Target customers
Healthcare & Life SciencesLife SciencesBiotechnologyPharmaceuticals